Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases. (Record no. 29666271)

MARC details
000 -LEADER
fixed length control field 00743 a2200193 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518040035.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1424-8247
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.3390/ph12020069
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Rodrigues, Daniel A
245 00 - TITLE STATEMENT
Title Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Pharmaceuticals (Basel, Switzerland)
Date of publication, distribution, etc. May 2019
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sagrillo, Fernanda S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fraga, Carlos A M
773 0# - HOST ITEM ENTRY
Title Pharmaceuticals (Basel, Switzerland)
Related parts vol. 12
-- no. 2
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.3390/ph12020069">https://doi.org/10.3390/ph12020069</a>
Public note Available from publisher's website

No items available.